Today we talk with Dr. Mark Lythgoe, a Clinical Research Fellow at Imperial College London, on his new paper titled "Race reporting and diversity in US food and drug administration (FDA) registration trials for prostate cancer; 2006-2020", out now in Prostate Cancer and Prostatic Diseases.

On today's episode, we invite Dr. Chris Whaley of RAND and Dr. Neeraj Sood of the USC Price School of Public Policy to discuss their new paper titled "Back to School: The Effect of School Visits During COVID-19 on COVID-19 Transmission", out now in the National Bureau of Economic Research

Today our guest is Dr. Paul Edward Sax, Clinical Director of the Infectious Disease Clinic and Professor of Medicine at Harvard Medical School. We talk about all things COVID-19.

On today's episode, we interview Dr. Roxana Daneshjou, a clinical scholar in dermatology and postdoctoral research fellow at Stanford University. We talk about artificial intelligence in dermatology and beyond

On today's episode, we have a short monologue for you on the recent CheckMate 577 study that was recently published in the New England Journal of Medicine. The title of the paper is "Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction

Today we're joined by Dr. Daniel Meyers of the University of Calgary who's here to discuss his new paper out now in the Journal of Cancer Policy. It's titled "Industry payments to US physicians for cancer therapeutics

Today we sit down with Dr. Kirsten Bibbins-Domingo, Chair of the Department of Epidemiology and Biostatistics and the inaugural Vice Dean for Population Health and Health Equity in the UCSF School of Medicine. We talk about mentorship throughout a career, the unique value of epidemiology and biostatistics, finding passion in your work, disparities in healthcare during the COVID-19 pandemic, and more.

Today we sit down with Dr. Monica Gandhi, Associate Division Chief of the Division of HIV, Infectious Diseases, and Global Medicine at UCSF/ San Francisco General Hospital, and medical director of the HIV Clinic at SFGH. We talk about ending COVID-19 pandemic restrictions, vaccination boosters, and more. She gives us the motivation we all need right now.

Today we talk with Dr. Manni Mohyuddin of Kansas University Medical Center on his new paper out now in JAMA Network Open titled "Reporting of Postprotocol Therapies and Attrition in Multiple Myeloma Randomized Clinical Trials: A Systematic Review".

On today's episode, we interview Dr. Jeffrey Flier, an esteemed endocrinologist and physician researcher who was Dean of the Faculty of Medicine at Harvard University for nine years (2007-2016). We talk about his career in academic medicine as well as the challenges of 2021.

Today we bring back popular guest Dr. David Russler-Germain, a Hematology/Oncology Fellow at the Washington University School of Medicine in St. Louis, to discuss his thoughts on PhD programs (in response to a listener question) as well as his take on Idecabtagene vicleucel for multiple myeloma.

Today we talk with Dr. Martin Kulldorff, a Professor of Medicine at Harvard Medical School and Brigham and Women's Hospital, about COVID-19 health policy and about disagreement.

Today we bring back popular guest Dr. Adam Cifu, a Professor of Medicine at the University of Chicago, to talk about the idea of banning books. the power of social media, and the current state of medical education.

Today we are joined by Samantha Godwin, a Resident Fellow for the Information Society Project at Yale Law School, to discuss COVID-19 health policy from a legal and philosophical perspective.

Today we talk again with Dr. David Russler-Germain, a Hematology/Oncology Fellow at the Washington University School of Medicine in St. Louis, this time on the Medical Scientist Training Program (MSTP).

Today we interview Dr. Tom Beer, the Deputy Director of the Oregon Health & Science University Knight Cancer Institute, about COVID-19 transmission, policy, and vaccines. We also talk about olaparib.

Today we are joined by guest Dr. Carl Hart, a behavioral neuroscientist and Professor of Psychology at Columbia University. We discuss his research, his philosophies, and his new book "Drug Use for Grown-Ups.”

Today we bring back popular guest Dr. Bernie Marini, a Clinical Pharmacist Specialist in Hematology at University of Michigan Medicine, to discuss treatment of Acute Lymphoblastic Leukemia (ALL).

Today we are joined by genomicist Dr. Nathan Pearson, founder of Root (rootdeep.com), to discuss which genetic alterations in the host predispose to SARS-CoV-2 acquisition and bad outcomes.

Today we bring back popular guest Jacob Hale Russell, an Associate Professor of Law at Rutgers Law School, for a discussion on expertise, disinformation, and intellectual disagreement.